Company: CRVO
Filing Date: 2025-05-12
Form Type: 424B5
Source: 0001437749-25-016167
Chunk: 14

Company: CervoMed Inc.
Filing Date: 2025-05-12
Form: 424B5
Chunk 14
---
 of the potential markets for our current or future product candidates, the rate and degree of market acceptance of any of our current or future product candidates that may be approved in the future, and our ability to serve those markets; |

| ● | the success of products that are or may become available which also target the potential markets for our current or future product candidates; |

| ● | our ability to operate our business without infringing the intellectual property rights of others and the potential for others to infringe upon our intellectual property rights; |

| ● | any significant breakdown, infiltration, or interruption of our information technology systems and infrastructure; |

<div align='center'>S-8</div>

| ● | our ability to remediate our previously disclosed material weaknesses in our internal controls over financial reporting in a timely manner; |

| ● | recently enacted and future legislation related to the healthcare system; |

| ● | other regulatory developments in the United States, European Union, and other foreign jurisdictions; |

| ● | our ability to satisfy the continued listing requirements of The NASDAQ Capital Market or any other exchange on which our securities may trade in the future; |

| ● | uncertainties related to general economic, political, business, industry, and market conditions, including the continued availability of funding for the NIA to support disbursements under our previously received grant; and |

| ● | other risks and uncertainties, including those discussed under the heading “Risk Factors” herein and in our other public filings incorporated by reference herein. |

You should also read carefully the factors described in the “Risk Factors” section contained in this prospectus supplement and any related free writing prospectus, and incorporated by reference herein from our Annual Report on Form 10-K filed with the SEC on March 17, 2025, as updated by annual, quarterly and other reports and documents we file with the SEC after the date of this prospectus supplement and that are incorporated by reference herein to better understand the risks and uncertainties inherent in our business and underlying any forward-looking statements. As a result of these and other factors, known and unknown, actual results could differ materially from our intentions, beliefs, projections, outlook, analyses, or expectations contained or incorporated by references in any forward-looking statements in this prospectus supplement. Accordingly, we cannot assure you that the forward-looking statements contained in or incorporated by reference into this prospectus supplement will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. You should also